AKT1 and diabetes mellitus: Catechin has been shown to inhibit inflammatory cytokines and activate AMP-dependent/activated protein kinase [99], protein kinase B (Akt) [100], ERK/JNK-p53, and other signaling pathways to maintain normal mitochondrial respiratory chain operation and exert specific therapeutic effects on diabetes in many studies [101].